hyperimmune plasma
/ ANd&tAT
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 06, 2022
Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection
(clinicaltrials.gov)
- P1/2 | N=72 | Completed | Sponsor: Andalusian Network for Design and Translation of Advanced Therapies | Recruiting ➔ Completed
Trial completion • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases • IL6
1 to 1
Of
1
Go to page
1